Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rasagiline for Sleep Disorders in Parkinson's Disease
2010-023756-82Phase 3Completed
- Sponsor
- Technische Universität Dresden
- Start
- Apr 2011
- Modality
- Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of rasagiline in Parkinson's disease (PD) and sleep disorder, sponsored by Technische Universität Dresden. Primary endpoints: Change in sleep efficiency and Change in Parkinson's Disease Sleep Scale-2. Started Apr 2011; status: completed.
02
Drugs
rasagiline
03
Conditions
Parkinson's disease (PD)sleep disorder
Beyond the preview
Go deeper on 2010-023756-82.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023756-82.